Search Results - "Rustin, G"

Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.

Authors: Burdett, Nikki L. Willis, Madelynne O. Pandey, Ahwan et al.

Source: Scientific Reports. 12/11/2023, Vol. 13 Issue 1, p1-10. 10p.

Depth of response to primary POMB/ACE chemotherapy predicts survival in poor prognosis germ-cell tumours.

Authors: Hobbs E Ulrich L Sharma A et al.

Source: British journal of cancer [Br J Cancer] 2026 May 28. Date of Electronic Publication: 2026 May 28.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Accelerated Bilateral Cataract Progression during Olaparib plus Bevacizumab Maintenance Therapy for High-Grade Serous Fallopian Tube Carcinoma: A Case Report.

Authors: Saito, Wataru Ota, Kuniaki Okamoto, Hana et al.

Source: Case Reports in Oncology. May2026, Vol. 19 Issue 1, p796-804. 9p. 4 Illustrations.

Synthesis and Characterization of Dual Natural Quercetin/Fucoidan Gene Delivery Nanoplatform for Synthetic Lethality in BRCA-Deficient Tumors.

Authors: Yeh, Jih-Hao Huang, Shih-Yu Chu, Ching-Chun et al.

Source: Polymers (20734360). Jun2026, Vol. 18 Issue 11, p1314. 21p.

Integrative transcriptomic analysis of Korean high-grade serous ovarian cancer.

Authors: Kim, Hyondeog Kim, Youngwook Park, Juyeong et al.

Source: PLoS Genetics. 9/15/2025, Vol. 21 Issue 9, p1-20. 20p.

Author index.

Source: British Journal of Cancer. 6/15/2001, Vol. 84 Issue 12, p1687. 8p.

MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.

Authors: Hasbay, Ebru Sahin, Sukru Kelten Talu, Esra Canan et al.

Source: PLoS ONE. 2/27/2026, Vol. 21 Issue 2, p1-13. 13p.

Author Index.

Source: BJU International. Jun2010 Supplement 1, Vol. 106, p63-66. 4p.

Author Index for Volume 99.

Source: British Journal of Cancer. 12/16/2008, Vol. 99 Issue 12, p2101-2109. 9p.

Smoking and bladder cancer: insights into pathogenesis and public health implications from a bibliometric analysis (1999–2023).

Authors: Wang, Yang Zhou, Hancheng Tang, Zhicheng et al.

Source: Substance Abuse Treatment, Prevention & Policy. 6/14/2025, Vol. 20 Issue 1, p1-13. 13p.

Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

Authors: Tatsuki, Shunsuke Shoji, Tadahiro Jo, Ami et al.

Source: Cancers. May2026, Vol. 18 Issue 9, p1332. 14p.

PARP Inhibitors and the Risk of Serum Creatinine Elevation in Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors: Gąsowska-Bodnar, Agnieszka Gąsowska-Bajger, Beata Żołnierek, Aleksandra et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1226. 11p.

Cure of Recurrent Ovarian Cancer: A Multicenter Retrospective Study.

Authors: Sumitomo, Masahiro Kotani, Yasushi Murakami, Kosuke et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p3069. 13p.

An Inducible BRCA1 Expression System with In Vivo Applicability Uncovers Activity of the Combination of ATR and PARP Inhibitors to Overcome Therapy Resistance.

Authors: Irving, Elsa Morcavallo, Alaide Vohhodina-Tretjakova, Jekaterina et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p309. 20p.

Efficacy of Chemotherapy Following Prior PARP-Inhibitor Treatment in Patients with Ovarian Cancer.

Authors: Kim, Jung Chul Park, Junsik Lee, Yong Jae et al.

Source: Cancer Research & Treatment. Jan2026, Vol. 58 Issue 1, p292-299. 8p.

SLX1 Inhibition Enhances Olaparib Sensitivity by Impairing Homologous Recombination Repair in Breast Cancer.

Authors: Kim, Jin-Young Kim, Jeeho Chang, In-Youb et al.

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 23, p11621. 17p.

Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells.

Authors: Komar, Zofia M. Ladan, Marjolijn M. Verkaik, Nicole S. et al.

Source: Cancers. Jul2025, Vol. 17 Issue 13, p2109. 14p.

Author Index for Volume 90.

Source: British Journal of Cancer. 6/14/2004, Vol. 90 Issue 12, p2426-2435. 10p.

Oncogenic EGFR Signaling as a Central Regulator of Chemoresistance in Ovarian Cancer: A Mechanistic Review.

Authors: Nagappan, Arulkumar Sethuraman, Veeran Pandian, Parthiban et al.

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p5937. 29p.

Prognostic, Predictive, and Clinical Relevance of DNA Damage Repair Alterations in Biliary Tract Cancers.

Authors: Tarfouss, Jawad Azurmendi Senar, Oier Stosic, Kosta et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2134. 25p.